ArticleOxford medical case reports2025
Erythema Induratum as a rare manifestation of cutaneous tuberculosis in a young woman: a case report.
Article in Oxford medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cutaneous tuberculosis (TB) is a rare form of extrapulmonary TB, often leading to diagnostic challenges due to its varied clinical presentation. Erythema induratum of Bazin (EIB), a type of lobular panniculitis, is a recognized manifestation of cutaneous TB. This report describes a 19-year-old woman who developed EIB, presenting with recurrent fever, night sweats, weight loss, and hyperpigmented nodular lesions on both lower extremities. Laboratory tests showed an elevated erythrocyte sedimentation rate and a positive tuberculin skin test, while histopathology confirmed lobular panniculitis. Pulmonary TB was excluded based on negative molecular testing and normal chest imaging. The patient was diagnosed with cutaneous TB and treated with WHO-recommended first-line anti-TB therapy, leading to significant clinical improvement. This case underscores the importance of early recognition and timely treatment of cutaneous TB to prevent complications and ensure optimal outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.